Medication info
Entisimba Tablet 20 mg (Simvastatin)

Entisimba Tablet 20 mg (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Korea Sintax Pharmaceutical Co., Ltd.
Appearance
Pale yellowish oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201907577 · Approved 2019.10.30 · Insurance code 623006210

Summary

Main use
Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of the risk of cardiovascular disease Adult patients at high risk of coronary heart disease events because of a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Adjust the dose as appropriate according to the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) For recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), see below (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on controlled clinical trial results, patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. This medicine should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are unavailable. (2) In elderly patients, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medicine is used concomitantly in patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medicine is used concomitantly in patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with bile acid sequestrants. When this medicine is used concomitantly with fibrates (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg per day. (6) Use in patients with renal impairment Because this medicine is not substantially excreted by the kidneys, no dose adjustment is needed in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg once daily and monitor carefully.
Child dose
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Ingredients

Manufacturer
Korea Sintax Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication reduces the risk of death from coronary heart disease in adults at high risk for cardiovascular disease, lowers the likelihood of non-fatal myocardial infarction and stroke, and decreases risks associated with vascular regeneration procedures. Additionally, it is used as an adjunct to dietary therapy to effectively lower total cholesterol, LDL cholesterol, and triglyceride levels, while increasing HDL cholesterol in patients with hyperlipidemia. It is especially useful in managing various types of hyperlipidemia, including primary dyslipidemia and familial hypercholesterolemia. It also helps improve total cholesterol and LDL cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia when combined with dietary control. This medication acts effectively to maintain cardiovascular health and improve hyperlipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of the risk of cardiovascular disease Adult patients at high risk of coronary heart disease events because of a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Adjust the dose as appropriate according to the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) For recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), see below (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on controlled clinical trial results, patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. This medicine should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are unavailable. (2) In elderly patients, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medicine is used concomitantly in patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medicine is used concomitantly in patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with bile acid sequestrants. When this medicine is used concomitantly with fibrates (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg per day. (6) Use in patients with renal impairment Because this medicine is not substantially excreted by the kidneys, no dose adjustment is needed in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg once daily and monitor carefully.

Child dose

Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Precautions

This medication is primarily used to lower blood cholesterol levels. When taking this medication, symptoms such as muscle pain or weakness may occur, so any such symptoms should be promptly reported to a physician. Especially when taking high doses or certain other medications together, the risk of muscle problems may increase. Patients with liver dysfunction or a history of liver disease should not take this medication and should have regular liver function tests. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication, and if pregnancy occurs during treatment, it should be stopped immediately. This medication may increase blood concentrations and the risk of side effects when taken with certain enzyme-inhibiting medications, so it is important to inform the physician or pharmacist of any other medications being taken. Elderly patients, patients with reduced kidney function, or patients with hypothyroidism should use this medication with caution, and regular testing is required. It is advisable to avoid certain foods, such as grapefruit juice, during the course of this medication. When receiving a new prescription from another physician while taking this medication, it is essential to inform them about this medication. In case of an overdose, general treatment is required, and the medication should be stored out of reach of children.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 88 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • immune-mediated necrotizing myopathy
  • specific cranial nerve dysfunction
  • taste alteration
  • ocular motility disorder
  • facial partial paralysis
  • tremor
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve palsy
  • psychiatric disorder
  • anxiety
  • sleep disorder
  • nightmares
  • depression
  • cognitive impairment
  • severe muscular weakness
  • ocular muscle weakness
  • hepatitis
  • liver dysfunction
  • jaundice
  • pancreatitis
  • cholestatic jaundice
  • liver fat changes
  • liver cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • anorexia
  • vomiting
  • alopecia
  • pruritus
  • skin changes
  • lichen planus-like drug rash
  • gynecomastia
  • reduced libido
  • sexual dysfunction
  • cataract progression
  • ocular muscle paralysis
  • anemia
  • elevated amino transferase
  • elevated ALP
  • elevated γ-GTP
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • increased fasting blood glucose levels
  • sensory numbness in limbs
  • tingling sensation
  • cold sensation
  • reduced muscle strength
  • thrombocytopenia
  • lupus erythematosus-like syndrome
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • arthralgia
  • urticaria
  • photophobia
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • erythema multiforme
  • interstitial lung disease
  • vomiting
  • mucous stools

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain storage temperatures between 1 and 30 degrees Celsius to preserve the drug's effectiveness over time.

Appearance and packaging

Appearance

Pale yellowish oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.